ABC’s Health Report covers Moxidectin approval

The interview covers MDGH’s business model, the FDA’s approval of Moxidectin, and the medicine’s potential to help the fight against river blindness, which is a leading global cause of preventable blindness. Click anywhere to listen to a recording on the ABC’s website. Open full article

The release as fetched from its publisher. medicinesdevelopment.com ↗